Notices. Notice of registration
331 words·~2 min read·
/register/2018/10/02/2018-21354·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration ACTION: Notice of registration. SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration
(DEA)as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices are listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Company FR Docket Published AMRI Rensselaer, Inc 83 FR 15176 April 9, 2018. S&B Pharma, Inc 83 FR 31421 July 5, 2018. Cerilliant Corporation 83 FR 32906 July 16, 2018. Shertech Laboratories, LLC 83 FR 34879 July 23, 2018. Fresenius Kabi USA, LLC 83 FR 34878 July 23, 2018. VHG Labs DBA LGC Standards 83 FR 34875 July 23, 2018. Catalent Pharma Solutions, LLC 83 FR 34874 July 23, 2018. Fisher Clinical Services, Inc 83 FR 34879 July 23, 2018. Anderson Brecon, Inc 83 FR 37525 August 1, 2018. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies. Dated: September 20, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-21354 Filed 10-1-18; 8:45 am]
Connectionstraces to 3
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources